Literature DB >> 1115367

Interaction of ketamine and halothane in rats.

P F White, R R Johnston, C R Pudwill.   

Abstract

The interaction of intramuscularly injected ketamine and its N-demethylated metabolite (metabolite I) with halothane was evaluated in rats. Five, 10, 20, or 50 mg/kg of ketamine alone or 20, 50, or 100 mg/kg of metabolite I alone produced less than 10 minutes of hypnosis. However, halothane anesthetic requirement (i.e., MAC) was depressed in a dose-dependent fashion as much as 56% 1-2 hours and as much as 14% 5-6 hours after injection of ketamine, 50 mg/kg, im. The reduction in MAC was correlated with brain levels of ketamine or metabolite I, suggesting a ketamine:metabolite I potency ration of 3:1. The half-life of ketamine in plasma and brain was longer in the presence of halothane than when ketamine was given alone. It is concluded that ketamine is not a short-acting drug and that concomitant use with halothane would be expected to prolong further the duration of its action on the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115367     DOI: 10.1097/00000542-197502000-00011

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  13 in total

1.  Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing.

Authors:  Samuel Fanta; Mari Kinnunen; Janne T Backman; Eija Kalso
Journal:  Eur J Clin Pharmacol       Date:  2015-03-01       Impact factor: 2.953

2.  Meperidine-halothane interaction in dogs.

Authors:  E P Steffey; R Martucci; D Howland; J H Asling; J H Eisele
Journal:  Can Anaesth Soc J       Date:  1977-07

3.  Pharmacokinetics of intravenous anaesthetics: implications for clinical use.

Authors:  M M Ghoneim; K Korttila
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

Review 4.  Safety considerations in the use of drug combinations during general anaesthesia.

Authors:  E S Ransom; R A Mueller
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

5.  [Circulatory and respiratory effects of ketamine in horses anesthetized with halothane].

Authors:  D Serteyn; D Blais; N A Abou Madi; P Coppens; E Mottart; C Philippart
Journal:  Can J Vet Res       Date:  1987-10       Impact factor: 1.310

Review 6.  Clinically important drug interactions with intravenous anaesthetics in older patients.

Authors:  Helge Eilers; Claus Niemann
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  The development of tolerance to ketamine in rats and the significance of hepatic metabolism.

Authors:  A Livingston; A E Waterman
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

8.  Effect of hyperbaric oxygenation on the Na+, K(+)-ATPase and membrane fluidity of cerebrocortical membranes after experimental subarachnoid hemorrhage.

Authors:  K Yufu; T Itoh; R Edamatsu; A Mori; M Hirakawa
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

Review 9.  Pharmacokinetic drug interactions in anaesthetic practice.

Authors:  M Wood
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

10.  Pharmacokinetics of sufentanil in normal children.

Authors:  J Guay; P Gaudreault; A Tang; B Goulet; F Varin
Journal:  Can J Anaesth       Date:  1992-01       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.